Highly SensitiveDetection of Engrailed‑2 ProteinBiomarker in Urine for Using Solution-Gated Graphene Transistor Diagnosisof Prostate Cancer

Engrailed-2 (EN2) protein, a transcription factor in the homologous domain expressed in prostate cancer (PCa) cells and secreted into the urine, is considered a promising biomarker for noninvasive detection of PCa. EN2 protein in urine samples can be obtained by noninvasive means, but the low biomarker concentration in urine samples poses a great challenge for noninvasive detection of the PCa biomarker. Herein, we develop a solution-gated graphene transistor (SGGT) biosensor to detect the biomarker of the EN2 protein for PCa diagnosis. The aptamer probes are immobilized to the gold gate electrode through Au–S bonds. The effect of aptamer configurations on the biosensor’s responses is also investigated. It can be found that the SGGT biosensor with the long-chain probes with a stem-like loop structure exhibits optimal performance. The limit of detection of biosensors can reach 0.1 fg/mL, and a rapid response time of 19 min is achieved. The SGGT biosensor also exhibits high specificity for the EN2 protein. More importantly, testing of clinical urine samples indicates that our sensor can distinguish PCa patients from non-PCa subjects. Compared to traditional hospital prostate-specific antigen tests, our sensor exhibits better accuracy for the noninvasive diagnosis of PCa.

Publication Details

Journal
Figshare
Published
2025-03-05
DOI
https://doi.org/10.1021/acssensors.4c03320.s001
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Highly SensitiveDetection of Engrailed‑2 ProteinBiomarker in Urine for Using Solution-Gated Graphene Transistor Diagnosisof Prostate Cancer

Figshare
Advanced biosensing and bioanalysis techniques
article

Highly SensitiveDetection of Engrailed‑2 ProteinBiomarker in Urine for Using Solution-Gated Graphene Transistor Diagnosisof Prostate Cancer

article en

Abstract

Engrailed-2 (EN2) protein, a transcription factor in the homologous domain expressed in prostate cancer (PCa) cells and secreted into the urine, is considered a promising biomarker for noninvasive detection of PCa. EN2 protein in urine samples can be obtained by noninvasive means, but the low biomarker concentration in urine samples poses a great challenge for noninvasive detection of the PCa biomarker. Herein, we develop a solution-gated graphene transistor (SGGT) biosensor to detect the biomarker of the EN2 protein for PCa diagnosis. The aptamer probes are immobilized to the gold gate electrode through Au–S bonds. The effect of aptamer configurations on the biosensor’s responses is also investigated. It can be found that the SGGT biosensor with the long-chain probes with a stem-like loop structure exhibits optimal performance. The limit of detection of biosensors can reach 0.1 fg/mL, and a rapid response time of 19 min is achieved. The SGGT biosensor also exhibits high specificity for the EN2 protein. More importantly, testing of clinical urine samples indicates that our sensor can distinguish PCa patients from non-PCa subjects. Compared to traditional hospital prostate-specific antigen tests, our sensor exhibits better accuracy for the noninvasive diagnosis of PCa.

Figshare
Openalex Percentile: Top 60%
Advanced biosensing and bioanalysis techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Highly SensitiveDetection of Engrailed‑2 ProteinBiomarker in Urine for Using Solution-Gated Graphene Transistor Diagnosisof Prostate Cancer · Figshare (2025) | TGRS Research Map | TGRS